A Comparison with Adverse Events Following Immunization Associated with Sabin-Strains and Salk-Strains Inactivated Polio Vaccines in Zhejiang Province, China

被引:3
|
作者
Lv, Huakun [1 ]
Pan, Xuejiao [1 ]
Liang, Hui [1 ]
Chen, Yaping [1 ]
Wang, Ying [1 ]
Chen, Fuxing [1 ]
Shen, Linzhi [1 ]
Hu, Yu [1 ]
机构
[1] Zhejiang Ctr Dis Control & Prevent, Inst Immunizat & Prevent, Hangzhou 310051, Peoples R China
关键词
adverse events following immunization; inactivated polio vaccine; Sabin-strains; Salk-strains; REPORTING SYSTEM; SURVEILLANCE; SAFETY; SEIZURES; ENDGAME;
D O I
10.3390/vaccines10020319
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objectives: One dose of Sabin-strains inactivated polio vaccine (IPV) was introduced into the Chinese immunization program on 1 May 2016. This study aimed to evaluate the safety of Sabin-strains IPV and provide a comparison with conventional Salk-strains IPV. Methods: Adverse events following immunization (AEFI) records associated with Sabin-strains IPV and Salk-strains IPV were extracted from the national AEFI surveillance system (NAEFISS) from 1 May 2016 to 31 December 2020. The vaccination information on Sabin-strains IPV and Salk-strains IPV during the same period was obtained from the Zhejiang provincial immunization information system. Reporting rates of AEFI were calculated by age, city, severity of AEFI, categories of AEFI, and reaction categories and were compared between Sabin-strains IPV and Salk-strains IPV. Results: In total, 3,861,758 doses of Sabin-strains IPV and 1,018,604 doses of Salk-strains IPV were administered during the study period. The overall AEFI reporting rate for Sabin-strains IPV (3.96/10,000 doses) was significantly lower than that for Salk-strains IPV (5.03/10,000 doses) due to the reporting rate of the minor vaccine product-related reaction following Sabin-strains IPV was significantly lower than that for Salk-strains IPV (2.76/10,000 doses vs. 3.83/10,000 doses). The most frequently reported symptoms/signs were fever, induration/swelling, and rash/urticaria. The most frequently reported serious AEFI with a causal relationship was febrile convulsion, with the reporting rates of 0.10/10,000 doses for Sabin-strains IPV and 0.08/10,000 doses for Salk-strains IPV. No significant difference was found in the reporting rates of the other serious AEFI between the two types of IPV. Conclusion: Most of the AEFI following Sabin-strains IPV and Salk-strains IPV were mild and common adverse reactions. The reporting rate of serious AEFI was not significantly different between Sabin-strains IPV and Salk-strains IPV. Sabin-strains IPV had a favorable safety profile and could be widely used.
引用
收藏
页数:11
相关论文
共 10 条
  • [1] Surveillance of adverse events following the introduction of inactivated poliovirus vaccine made from Sabin strains (sIPV) to the Chinese EPI and a comparison with adverse events following inactivated poliovirus vaccine made from wild strains (wIPV) in Jiangsu, China
    Kang, Guodong
    Tang, Fenyang
    Wang, Zhiguo
    Hu, Ran
    Yu, Jing
    Gao, Jun
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2021, 17 (08) : 2568 - 2574
  • [2] Innovation amidst post-socialist reform: Jonas Salk and the birth of the Sabin strains-derived inactivated polio vaccine in China
    Li, Tianyu
    Wang, Chadwick
    BRITISH JOURNAL FOR THE HISTORY OF SCIENCE, 2025,
  • [3] Surveillance for Adverse Events following Immunization from 2008 to 2011 in Zhejiang Province, China
    Hu, Yu
    Li, Qian
    Lin, Luoya
    Chen, Enfu
    Chen, Yaping
    Qi, Xiaohua
    CLINICAL AND VACCINE IMMUNOLOGY, 2013, 20 (02) : 211 - 217
  • [4] Barriers to healthcare workers reporting adverse events following immunization in Zhejiang province, China
    Lv, Huakun
    Pan, Xuejiao
    Wang, Ying
    Liang, Hui
    Yu, Hu
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2022, 18 (05)
  • [5] Analysis of the adverse events following immunization with inactivated quadrivalent influenza vaccine from 2018 to 2020 in Zhejiang province, with a comparison to trivalent influenza vaccine
    Lv, Huakun
    Pan, Xuejiao
    Liang, Hui
    Wang, Ying
    Hu, Yu
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2021, 17 (11) : 4617 - 4622
  • [6] Surveillance of Adverse Events Following Varicella Vaccine Immunization in Zhejiang Province, China, from 2020 to 2022
    Liang, Hui
    Qi, Xiaohua
    Chen, Yaping
    Pan, Xuejiao
    VACCINES, 2025, 13 (01)
  • [7] Safety and 6-month immune persistence of inactivated poliovirus vaccine (Sabin strains) simultaneously administrated with other vaccines for primary and booster immunization in Jiangxi Province, China
    Guo, Shicheng
    Li, Zhen
    Zheng, Min
    Wu, Fengyun
    Sun, Jianwen
    Tuo, Ling
    Li, Su
    Li, Xiang
    Wei, Lijuan
    Xia, Zhiyong
    Xie, Pinxing
    Chen, Xiaomei
    Zhao, Yanwei
    Gao, Yongjun
    Yu, Dan
    VACCINE, 2024, 42 (21)
  • [8] Knowledge, perceptions, and practice towards adverse events following immunization surveillance among vaccination workers in Zhejiang province, China
    Huakun Lv
    Xuejiao Pan
    Ying Wang
    Hui Liang
    Hu Yu
    Asian Pacific Journal of Tropical Medicine, 2023, (03) : 102 - 109
  • [9] Knowledge, perceptions, and practice towards adverse events following immunization surveillance among vaccination workers in Zhejiang province, China
    Lv, Huakun
    Pan, Xuejiao
    Wang, Ying
    Liang, Hui
    Yu, Hu
    ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE, 2023, 16 (03) : 102 - 109
  • [10] Surveillance of adverse events following immunization of 13-valent pneumococcal conjugate vaccine among infants, in Zhejiang province, China
    Hu, Yu
    Pan, Xuejiao
    Chen, Fuxing
    Wang, Ying
    Liang, Hui
    Shen, Linzhi
    Chen, Yaping
    Lv, Huakun
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2022, 18 (01)